Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMTEY8W)

Drug Name

E-6276 Drug Info

Synonyms

1-(2-Benzhydrylideneaminooxy-ethyl)-1,2,5,6-tetrahydro-pyridine-3-carboxylic acid; UNII-BGU9MZ2G30; BGU9MZ2G30; CHEMBL473104; 159094-94-7; Tocris-1779; Lopac-N-142; Biomol-NT_000271; AC1L1IC7; Lopac0_000880; SCHEMBL5969062; GTPL4669; BPBio1_000948; CTK0H8642; CHEBI:92744; DTXSID30166582; ZINC1534967; BDBM50426075; BDBM50080344; AKOS030543350; CCG-204962; 3-Pyridinecarboxylic acid, 1-(2-(((diphenylmethylene)amino)oxy)ethyl)-1,2,5,6-tetrahydro-; NCGC00015712-05; NCGC00015712-02; NCGC00025293-03; NCGC00025293-02; NCGC00015712-04; NCGC00025293-01; NCGC00015712-03; NCGC00015712-01; LS-187291

Indication

Disease Entry	ICD 11	Status	REF
Schizophrenia	6A20	Terminated	[1]

Cross-matching ID

PubChem CID: 4515
ChEBI ID: CHEBI:92744
CAS Number: CAS 159094-94-7
TTD Drug ID: DMTEY8W

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Approved Drug(s)

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Opioid receptor sigma 1 (OPRS1)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Dextromethorphan	DMUDJZM	Allergic rhinitis	CA08.0	Approved	[2]
Dextromethorphan Polistirex	DMEHCY5	Dry cough	MD12	Approved	[3]
CM-2395	DMASPWR	Schizophrenia	6A20	Phase 3	[4]
AVP-786	DMV1SOR	Alzheimer disease	8A20	Phase 3	[5]
ADX N05	DMLBYRA	Mood disorder	6A60-6E23	Phase 3	[6]
Igmesine	DMH97XA	Major depressive disorder	6A70.3	Phase 2	[7]
OPC-14523	DMB1WF3	Bulimia nervosa	6B81	Phase 2	[8]
ANAVEX 2-73	DM67OU4	Alzheimer disease	8A20	Phase 1	[9]
SSR-125047	DMSUFW6	Schizophrenia	6A20	Phase 1	[1]
SA-5845	DM6XZRL	Central nervous system disease	8A04-8D87	Phase 1	[10]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Opioid receptor sigma 1 (OPRS1)	TT5TPI6	SGMR1_HUMAN	Binder	[1]

------------------------------------------------------------------------------------

References

1	The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22.
2	Dextromethorphan/quinidine: AVP 923, dextromethorphan/cytochrome P450-2D6 inhibitor, quinidine/dextromethorphan. Drugs R D. 2005;6(3):174-7.
3	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
4	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800031127)
5	Antitussives and substance abuse. Subst Abuse Rehabil. 2013 Nov 6;4:75-82.
6	Clinical pipeline report, company report or official report of SK BioPhamaceuticals.
7	Antiamnesic and neuroprotective effects of donepezil against learning impairments induced in mice by exposure to carbon monoxide gas. J Pharmacol Exp Ther. 2006 Jun;317(3):1307-19.
8	Antidepressant-like responses to the combined sigma and 5-HT1A receptor agonist OPC-14523. Neuropharmacology. 2001 Dec;41(8):976-88.
9	2011 Pipeline of Anavex.
10	Tumor imaging with 2 sigma-receptor ligands, 18F-FE-SA5845 and 11C-SA4503: a feasibility study. J Nucl Med. 2004 Nov;45(11):1939-45.